Nature Communications (Feb 2021)
Author Correction: Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients
- Yongliang Zhang,
- Yu Yao,
- Yaping Xu,
- Lifeng Li,
- Yan Gong,
- Kai Zhang,
- Meng Zhang,
- Yanfang Guan,
- Lianpeng Chang,
- Xuefeng Xia,
- Lin Li,
- Shuqin Jia,
- Qiang Zeng
Affiliations
- Yongliang Zhang
- Health Management Institute, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital
- Yu Yao
- Department of Medical Oncology, The First Affiliated Hospital of Xi’an Jiaotong University
- Yaping Xu
- Geneplus-Beijing Institute
- Lifeng Li
- Geneplus-Beijing Institute
- Yan Gong
- Health Management Institute, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital
- Kai Zhang
- Department of Cancer Prevention, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
- Meng Zhang
- Department of Molecular Diagnostics, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute
- Yanfang Guan
- Geneplus-Beijing Institute
- Lianpeng Chang
- Geneplus-Beijing Institute
- Xuefeng Xia
- Geneplus-Beijing Institute
- Lin Li
- Department of Medical Oncology, Beijing Hospital, National Center of Gerontology
- Shuqin Jia
- Department of Molecular Diagnostics, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute
- Qiang Zeng
- Health Management Institute, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital
- DOI
- https://doi.org/10.1038/s41467-021-21285-2
- Journal volume & issue
-
Vol. 12,
no. 1
pp. 1 – 1
Abstract
A Correction to this paper has been published: https://doi.org/10.1038/s41467-021-21285-2
